We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
+26.93%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105B
AUM Growth
+$9.87B
(+10%)
Cap. Flow
-$5.55B
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
2,219
New
117
Increased
528
Reduced
975
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$446M |
| 2 |
Cisco
CSCO
|
+$406M |
| 3 |
Snowflake
SNOW
|
+$271M |
| 4 |
Visa
V
|
+$220M |
| 5 |
APi Group
APG
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$893M |
| 2 |
Palo Alto Networks
PANW
|
+$583M |
| 3 |
Microsoft
MSFT
|
+$480M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$474M |
| 5 |
Marvell Technology
MRVL
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.26% |
| 2 | Industrials | 13.78% |
| 3 | Healthcare | 11.68% |
| 4 | Financials | 8.38% |
| 5 | Consumer Discretionary | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
German American Bancorp
GABC
$1.87B
| $257K | ﹤0.01% |
5,409
| – | – |
|
1852
Astrana Health
ASTH
$1.86B
| $256K | ﹤0.01% |
+5,510
| New | +$198K |
|
1853
Protolabs
PRLB
$2.14B
| $256K | ﹤0.01% |
3,135
-639
| -17% | -$44.9K |
|
1854
Bausch Health
BHC
$2.37B
| $255K | ﹤0.01% |
51,827
-2,342
| -4% | -$12.6K |
|
1855
Edgewise Therapeutics
EWTX
$4.84B
| $255K | ﹤0.01% |
6,280
-1,343
| -18% | -$46.3K |
|
1856
Insperity
NSP
$1.96B
| $255K | ﹤0.01% |
+6,166
| New | +$202K |
|
|
ORC
1857
Orchid Island Capital
ORC
$1.3B
| $254K | ﹤0.01% |
36,438
+13,457
| +59% | +$92.8K |
|
1858
Brown-Forman Class A
BF.A
$13.2B
| $254K | ﹤0.01% |
+9,281
| New | +$255K |
|
1859
Fortrea Holdings
FTRE
$1.81B
| $254K | ﹤0.01% |
14,578
| – | – |
|
1860
Innoviva
INVA
$1.49B
| $253K | ﹤0.01% |
11,162
| – | – |
|
1861
Boston Beer
SAM
$1.86B
| $253K | ﹤0.01% |
1,430
-30
| -2% | -$6.08K |
|
1862
NovoCure
NVCR
$2.02B
| $253K | ﹤0.01% |
16,684
-3,161
| -16% | -$47.8K |
|
1863
Vermilion Energy
VET
$1.75B
| $253K | ﹤0.01% |
27,011
-6,293
| -19% | -$74.8K |
|
1864
Alamo Group
ALG
$2.06B
| $252K | ﹤0.01% |
1,533
| – | – |
|
1865
Hillman Solutions
HLMN
$1.77B
| $252K | ﹤0.01% |
29,804
| – | – |
|
1866
Melco Resorts & Entertainment
MLCO
$2.12B
| $252K | ﹤0.01% |
47,727
| – | – |
|
|
MANE
1867
Veradermics Inc
MANE
$4.63B
| $251K | ﹤0.01% |
+2,042
| New | +$191K |
|
1868
ManpowerGroup
MAN
$2.63B
| $251K | ﹤0.01% |
7,423
-1,582
| -18% | -$48.4K |
|
1869
National Bank Holdings
NBHC
$1.91B
| $251K | ﹤0.01% |
5,639
| – | – |
|
1870
TriCo Bancshares
TCBK
$1.82B
| $250K | ﹤0.01% |
4,645
| – | – |
|
|
TE
1871
T1 Energy
TE
$1.48B
| $249K | ﹤0.01% |
26,263
| – | – |
|
1872
Flywire
FLYW
$2.11B
| $249K | ﹤0.01% |
14,168
-3,785
| -21% | -$55.9K |
|
1873
Avis
CAR
$4.9B
| $249K | ﹤0.01% |
1,681
-1,254
| -43% | -$276K |
|
1874
Stoke Therapeutics
STOK
$2.08B
| $248K | ﹤0.01% |
7,581
| – | – |
|
1875
Kohl's
KSS
$2.16B
| $248K | ﹤0.01% |
13,981
-3,848
| -22% | -$57.1K |
|
Similar funds
Pictet Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Pictet Asset Management held 2,219 positions worth $105B, up 10% from $94.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Pictet Asset Management withdrew a net $5.55B in Q2 2026, closing 77 positions and reducing 975 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $87.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Pictet Asset Management opened a new position in Madison Air Solutions worth $173M.
- Pictet Asset Management's largest Q2 2026 buy was Madison Air Solutions: 4,434,713 shares worth $173M.
- Pictet Asset Management added most to Vertiv in Q2 2026, an estimated $446M increase.
- Pictet Asset Management's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $893M.
- Pictet Asset Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $87.3M.
- Pictet Asset Management's ten largest holdings make up 22% of its $105B portfolio in Q2 2026.
- Pictet Asset Management opened 117 new positions and closed 77 in Q2 2026.
- Pictet Asset Management's portfolio value rose 10% quarter-over-quarter to $105B.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.